Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center and the Marvin and Concetta Greenberg Pancreatic Cancer Institute were recently renewed as a Clinical Center of Excellence and named for the first time as an Academic Center of Excellence for Pancreatic Cancer by the National Pancreas Foundation. Read More

UAMS Winthrop P. Rockefeller Cancer Institute The Association of American Medical Colleges (AAMC) recently bestowed the Spencer Foreman Award for Outstanding Community Engagement on the University of Arkansas for Medical Sciences (UAMS). The award is presented annually to an AAMC-member medical school or teaching hospital with a long-standing, major institutional commitment to partnering with the community it serves. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Baylor College of Medicine and Stanford University received an award for more than $25 million over five years from the National Institutes of Health to continue building the Clinical Genome (ClinGen) Resource, an effort to create expert curated knowledge about clinically relevant genes and genomic variants for use in precision medicine. The award is one of three NIH grants totaling $73.2 million over five years for t…

Stanford Cancer Institute Crystal Mackall, MD, director of the Stanford Center for Cancer Cell Therapy, was awarded nearly $12 million to investigate whether CAR T cell therapy can be modified to target a brain and spinal cord cancer called diffuse midline glioma. Read More

Duke Cancer Institute, Duke University Medical Center Duke University is the recipient of two large grants totaling nearly $12 million from the National Human Genome Research Institute as part of its new Impact of Genomic Variation on Function Consortium. The consortium will bring investigators together in a highly collaborative effort to examine how genomes function, how genome function shapes phenotypes, and how these processes are influenced by genomic variation. Read More

Roswell Park Comprehensive Cancer Center Teams of researchers from Roswell Park Comprehensive Cancer Center and the University of Chicago Medicine Comprehensive Cancer Center are combining efforts after together securing a nearly $9 million grant from the National Cancer Institute to develop new and better treatments for ovarian cancer. Read More

UCLA Jonsson Comprehensive Cancer Center Alice Soragni, PhD, has received a $2.5 million grant from the National Cancer Institute to develop lab-grown mini tumors that can help identify treatments for rare types of neuroendocrine cancer. The grant is a joint partnership with Patricia Dahia, MD, PhD, of the University of Texas Health Science Center at San Antonio. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute predoctoral fellow Prasoona Karra, MS, was selected to receive the National Cancer Institute (NCI) Predoctoral to Postdoctoral Fellow Transition Award. These awards are presented to “outstanding predoctoral researchers” and are designed to support them in the late stages of PhD training through transition to postdoctoral position. The award provides up to six years of funding. Read More

Vanderbilt-Ingram Cancer Center The Meharry Medical College/Vanderbilt-Ingram Cancer Center/Tennessee State University Partnership (MVTCP) has received renewed funding for the next five years to continue collaborations to eliminate cancer health disparities. Entering its 22nd consecutive year of funding, the MVTCP is the longest-standing partnership supported through the National Cancer Institute's U54 Comprehensive Partnerships to Advance Cancer Health Equity program. Read More

Robert H. Lurie Comprehensive Cancer Center of Northwestern University Neurosurgical oncologist, Amy Heimberger, MD, has joined the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as the Jean Malnati Miller Professor of Brain Tumor Research and scientific director of the Lou and Jean Malnati Brain Tumor Institute of the Lurie Cancer Center. Read More

Masonic Cancer Center, University of Minnesota Aaron Schilz, MPA, has been appointed as the interim executive director for the Masonic Cancer Center. He assumes the position previously held by Seanne Falconer, MBA, FACHE, who has accepted the role of executive director, administration at the Moores Cancer Center at UC San Diego Health. Read More

Ellen and Ronald Caplan Cancer Center of The Wistar Institute The Wistar Institute welcomes Amelia Escolano, PhD, and Nan Zhang, PhD, as assistant professors. Dr. Escolano’s research focuses on the development of novel vaccine approaches against highly mutating viruses. Dr. Zhang studies the role of a group of white blood cells known as macrophages during ovarian cancer metastasis in the abdominal cavity. Read More

Roswell Park Comprehensive Cancer Center Carl Morrison, MD, DVM, has been promoted to chair of pathology and laboratory medicine. Dr. Morrison, who joined Roswell Park in 2007, remains senior vice president for scientific development and integrative medicine. Read More

Huntsman Cancer Institute at the University of Utah Cells have quality controls, or checkpoints, to keep mistakes from happening. One of the last steps in cell division is a quality control process called the abscission checkpoint. If that checkpoint doesn’t work, cells divide even with mistakes present. This contributes to a higher risk of several kinds of cancer. Collaborative research from labs at Huntsman Cancer Institute looks at how the abscission checkpoint functions. Rea…

The University of Texas MD Anderson Cancer Center A new discovery from researchers at The University of Texas MD Anderson Cancer Center has clarified the long-established connection between inflammation and pancreatic cancer development. According to the study, pancreatic cells display an adaptive response to repeated inflammatory episodes that initially protects against tissue damage but can promote tumor formation in the presence of mutant KRAS. Read More

The University of Kansas Cancer Center The University of Kansas Cancer Center was invited to participate in a national pilot project being conducted by the American Society of Clinical Oncology and the Association of Community Cancer Centers. The pilot project is testing a research site self-assessment tool and an implicit bias training program focused on increasing racial and ethnic diversity among cancer treatment trial participants. Read More

University of Illinois Cancer Center University of Illinois Cancer Center researchers have discovered a potential drug target for treating aggressive pancreatic cancer. Their findings showed that an experimental compound inhibited pancreatic cancer in mice, significantly extending their survival and reducing tumor growth in a mouse model of pancreatic ductal adenocarcinoma. Read More

Siteman Cancer Center Blood and urine tests could lead to faster and less invasive methods to diagnose and monitor various types of tumors, according to new research from Washington University scientists at Siteman Cancer Center. Two studies describe the potential of liquid biopsies to identify and track tumor growth in bladder cancer and peripheral nerve tumors. Read More

Sidney Kimmel Cancer Center at Jefferson Health Tebentafusp, an investigational bispecific fusion protein, significantly improves overall survival among patients with metastatic uveal melanoma, according to results from a multicenter, randomized, Phase III clinical trial. Read More

Fred Hutchinson Cancer Center A new computational method called CoNGA could help bring into focus the hidden biological patterns that link T-cell receptor, or TCR, gene sequences and T-cell function. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute A study at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute turns cancer scientists into molecular detectives, searching for clues for why certain cancers are able to spread and evolve by studying tissues collected within hours of death. The Rapid Cancer Research Autopsy Trial allows scientists to gather biological samples …

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumors’ genes and proteins. Read More

UCSF Helen Diller Family Comprehensive Cancer Center UCSF researchers discover a new role for Erα as an RNA-binding protein, offering clues to overcoming resistance to therapies like tamoxifen that are used in many types of breast cancer. Read More

Cedars-Sinai Cancer Cedars-Sinai Cancer researchers have created a new system for classifying melanoma when the disease has spread to the lymph nodes. This system may offer a better tool for predicting patients' outcomes and determining their treatment needs. Read More

The University of Arizona Cancer Center The University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors. Read More

USC Norris Comprehensive Cancer Center New research reveals children born with a genetic predisposition to produce more lymphocytes, particularly in relation to other types of white blood cells, are at a higher risk of developing acute lymphoblastic leukemia. Read More

UK Markey Cancer Center A new study from UK Markey Cancer Center researchers demonstrate a combination of two drugs may be useful to treat ovarian cancers that are resistant to paclitaxel. Read More

Wilmot Cancer Institute, UR Medicine Individuals diagnosed with intrahepatic cholangiocarcinoma, a type of liver cancer, face a five-year survival rate of less than 10 percent. But a Wilmot Cancer Institute team that also investigates pancreatic cancer, which has similarly poor survival statistics, discovered factors that both aggressive cancers have in common. Read More

University of Michigan Rogel Cancer Center Communication between patients and their primary care providers is key to ensuring effective cancer care, both before diagnosis and after treatment, according to two recent papers led by University of Michigan Rogel Cancer Center researchers. Read More

The University of Texas MD Anderson Cancer Center A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Read More

Case Comprehensive Cancer Center Researchers from the Case Comprehensive Cancer Center have uncovered the potentially important role of the protein-coding gene, MYO10, in tumor development and immune therapy response. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University In human cancer cell and mouse studies, researchers from Johns Hopkins Medicine have found that a set of proteins work in tandem to build supply lines that deliver oxygen and nutrients to tumors, enabling them to survive and grow. Read More

Stanford Cancer Institute In a recent study, a team of Stanford researchers identified hundreds of potential targets for cancer therapies using a new screening strategy that allows for the systematic activation and deactivation of thousands of genes in both cancer cells and immune cells. Read More

Sidney Kimmel Cancer Center at Jefferson Health Video-based education is an acceptable pretesting alternative to traditional consultations with a genetic counselor for many men with prostate cancer or at-risk for prostate cancer who have been referred for genetic testing, according to results from the Evaluation and Management for Prostate Oncology, Wellness, and Risk study from researchers at the Sidney Kimmel Cancer Center at Jefferson Health. Read More

UCSF Helen Diller Family Comprehensive Cancer Center Under the leadership of Ana Velázquez Mañana, MD, fellow in medical oncology, UCSF, was chosen as one of only five institutions nationwide to participate in the American Society of Clinical Oncology's (ASCO) inaugural Oncology Summer Internship program to increase diversity in the oncology workforce. Read More

The University of Kansas Cancer Center National Cancer Institute Director Ned Sharpless, MD, and Office of Cancer Centers Director Henry Ciolino, PhD, joined Roy Jensen, MD, director of The University of Kansas Cancer Center, for a special episode of the center’s Facebook Live series "Bench to Bedside" on September 29 to discuss the 50th anniversary commemoration of the National Cancer Act, as well as the latest in cancer research, the impact of the COVID-19 pandemic on cancer research, …

The University of Arizona Cancer Center An enzyme with an elusive role in severe inflammation may be a key mechanism driving COVID-19 severity and could provide a new therapeutic target to reduce COVID-19 mortality, according to a study by researchers from the University of Arizona, in collaboration with Stony Brook University and Wake Forest School of Medicine. Read More